Subscribe
A worldwide window to Cambridge business, innovation and technology
Cambridge on song as ARIA orchestrates brain health revolution

Cambridge on song as ARIA orchestrates brain health revolution

A large cohort spanning the Cambridge life sciences, technology and business worlds has announced a multi-million-pound, three-year collaboration with the Advanced Research and Invention Agency (ARIA), the UK Government’s new research funding agency.
Mestag Therapeutics lines up potential $1.9bn haul from MSD

Mestag Therapeutics lines up potential $1.9bn haul from MSD

Mestag Therapeutics, a Cambridge biotech harnessing new insights into fibroblast-immune interactions, has entered into a license and collaboration agreement with MSD (tradename of Merck & Co., Inc) to identify novel targets for the development of therapies against inflammatory diseases.
LoQus23 Therapeutics raises £35m to fight Huntington’s disease

LoQus23 Therapeutics raises £35m to fight Huntington’s disease

Cambridge biotech LoQus23 Therapeutics has closed a £35 million (c.$43m) Series A to advance its fight against Huntington’s disease.
Game-changing AI camera launched by Raspberry Pi and Sony

Game-changing AI camera launched by Raspberry Pi and Sony

Japan’s Sony Semiconductor Solutions Corporation (SSS) and Cambridge UK quoted company Raspberry Pi have launched a jointly developed AI camera.
Cambridge the honey pot for US again as Visa swoops for Featurespace in c$1bn deal

Cambridge the honey pot for US again as Visa swoops for Featurespace in c$1bn deal

Cambridge-based online fraudbuster Featurespace is to be acquired by San Francisco company Visa – quoted on the New York Stock Exchange – for an undisclosed sum. Business Weekly has fielded reports from California that Visa could pay close to $1 billion.
Academia
Sharewatch
Manufacturing
Cambridge Judge Business School and Cranfield back new MBA scholarships for scientists
11 Oct 2024 - 12:00
Finalists chosen to pitch at Norwich innovation showcase
07 Oct 2024 - 12:00
Cambridge showcase aims to supercharge female entrepreneurship
19 Sep 2024 - 12:00

Business awards

Entries now being accepted

Business directory

Browse our listings of Cambridge companies

The killer 50

The 50 hottest disruptive technology companies

News

Cambridge Judge Business School and Cranfield back new MBA scholarships for scientists

Cambridge Judge Business School and Cranfield back new MBA scholarships for scientists

Cambridge Judge Business School and Cranfield School of Management are among six organisations promoting new MBA scholarships for scientists. The programme forms part of an initiative to make the UK a tech superpower.
Treatt share price takes off as results rocket

Treatt share price takes off as results rocket

CEO David Shannon said the company was poised to target new customers and markets in fresh global territories now a period of settling in at a new Bury St Edmunds HQ had helped build a platform for strong and sustained growth.
Mills & Reeve advises Gearset on maiden acquisition

Mills & Reeve advises Gearset on maiden acquisition

National law firm Mills & Reeve advised Cambridge-based Salesforce DevOps solutions provider, Gearset, on its first acquisition as part of an ambitious growth strategy. Gearset bought London-based Clayton, a cutting-edge code analysis platform designed specifically for Salesforce, following years of rapid growth, fuelled by a $55 million growth investment from Silversmith Capital Partners.
Mestag Therapeutics lines up potential $1.9bn haul from MSD

Mestag Therapeutics lines up potential $1.9bn haul from MSD

Mestag Therapeutics, a Cambridge biotech harnessing new insights into fibroblast-immune interactions, has entered into a license and collaboration agreement with MSD (tradename of Merck & Co., Inc) to identify novel targets for the development of therapies against inflammatory diseases.
More news

Tech trail

Neutreeno poised to clean up in $130 Trillion decarbonisation market

Neutreeno poised to clean up in $130 Trillion decarbonisation market

Neutreeno, a pioneering DeepTech startup spinning out of the University of Cambridge, has secured $5 million seed cash from a global syndicate of mission-aligned investors to target a $130 trillion decarbonisation market.
Timely $5.3 million helps clock.bio boost rejuvenation roadmap

Timely $5.3 million helps clock.bio boost rejuvenation roadmap

Cambridge-based clock.bio, a healthspan biotech working to reverse ageing, has raised $5.3 million seed funding led by LocalGlobe, with participation from BlueYard Capital, Onsight Ventures and serial Cambridge life science entrepreneur Dr Jonathan Milner.
LoQus23 Therapeutics raises £35m to fight Huntington’s disease

LoQus23 Therapeutics raises £35m to fight Huntington’s disease

Cambridge biotech LoQus23 Therapeutics has closed a £35 million (c.$43m) Series A to advance its fight against Huntington’s disease.
J.P. Morgan and CIC leverage Cambridge Entrepreneurs Forum to inspire future growth

J.P. Morgan and CIC leverage Cambridge Entrepreneurs Forum to inspire future growth

Last week, in partnership with Cambridge Innovation Capital, J.P. Morgan hosted its annual Cambridge Entrepreneurs Forum, bringing together J.P. Morgan’s leading multi-disciplinary capabilities to address the opportunities and challenges of scaling up ambitious UK companies with a global outlook.
More Tech trail

Trade floor

Milbank Group acquires Superfine Manufacturing Ltd

Milbank Group acquires Superfine Manufacturing Ltd

Milbank Group, a privately owned investment company based in Colchester, continues to grow its diversified portfolio of businesses following the acquisition of Superfine Manufacturing Ltd.
Streets reveals fifth merger in last six months with more to follow

Streets reveals fifth merger in last six months with more to follow

Streets Chartered Accountants, with Cambridge and other East of England operations, has further bolstered its UK reach in a deal that unites two pioneering tech-powered firms following its merger with Mitch Consulting.
Tessellate BIO in historic cancer research initiative

Tessellate BIO in historic cancer research initiative

Tessellate BIO, which has research labs at the Stevenage Bioscience Catalyst, has joined forces with Australasian power players Omico and Children's Medical Research Institute (CMRI) to initiate groundbreaking cancer research.
Cambridge the honey pot for US again as Visa swoops for Featurespace in c$1bn deal

Cambridge the honey pot for US again as Visa swoops for Featurespace in c$1bn deal

Cambridge-based online fraudbuster Featurespace is to be acquired by San Francisco company Visa – quoted on the New York Stock Exchange – for an undisclosed sum. Business Weekly has fielded reports from California that Visa could pay close to $1 billion.
Cambridge easy prey for big bucks buyers from US

Cambridge easy prey for big bucks buyers from US

Featurespace’s impending sale to Visa is just the latest in a series of acquisitions of world-leading Cambridge technology companies by big bucks US buyers in recent months.
More Trade floor